Previous 10 | Next 10 |
2024-03-07 12:49:07 ET More on Mid-day movers & stocks. Financial information for Nature Wood Group Financial information for Psyence Biomedical Ltd. Read the full article on Seeking Alpha For further details see: PBM and NWGL among mid-day movers
2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-07 09:09:27 ET CERo Therapeutics ( CERO ) +625% after announces publication of preclinical research supporting the use of its clinical candidate CER-1236 to treat AML patients . Lytus Technologies ( LYT ) +210% after enters $326 billion data center market...
2024-03-07 07:13:09 ET More on Immuron Financial information for Immuron Read the full article on Seeking Alpha For further details see: Immuron surges after mid-stage data for antidiarrheal med
2024-03-07 06:52:16 ET DENVER, Colo., Mar 07, 2024 ( 247marketnews.com )- Immuron Limited (NASDAQ: IMRN ) reported, this morning, that the interim topline results confirm that a single daily dose of Travelan is effective in prevention of moderate to severe diarrhea following challen...
Highlights: Immuron proceeding to Phase 3 registration strategy with the FDA Travelan® topline clinical trial results demonstrate protective efficacy with single daily dose 36.4% protective efficacy against Enterotoxigenic Escherichia coli (ETEC) induc...
MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Fes...
2024-02-13 07:37:39 ET More on Immuron Financial information for Immuron Read the full article on Seeking Alpha For further details see: Immuron up 3% on record Travelan sales
Highlights: Travelan ® sales YTD Jan 2024 of $2.7 million exceed peak full year FY20 sales of $2.5 million Australian Travelan ® YTD Jan 2024 sales $2.1 million USA Travelan ® YTD Jan 2024 sales $0.6 million Canadian sales recommenc...
Highlights: Record half yearly Travelan ® sales of $2,334,969 Total sales of A$2,355,580 in H1, FY24 $1,771,932 increase on H1, FY23 sales 51% higher than pre-pandemic period H1, FY20 sales MELBOURNE, Australia, Jan. 16, 2024 (GLOBE NEWSW...
News, Short Squeeze, Breakout and More Instantly...
Immuron Limited Company Name:
IMRN Stock Symbol:
NASDAQ Market:
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated b...
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore together with our Chief Scientific Officer, Dr. Jerry Kanello...
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6...